BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019;20:83-93. [PMID: 30546103 DOI: 10.1038/s41583-018-0097-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
Number Citing Articles
1 Chunduri A, Crusio WE, Delprato A. Narcolepsy in Parkinson's disease with insulin resistance. F1000Res 2020;9:1361. [PMID: 34745571 DOI: 10.12688/f1000research.27413.2] [Reference Citation Analysis]
2 Duffet L, Kosar S, Panniello M, Viberti B, Bracey E, Zych AD, Radoux-Mergault A, Zhou X, Dernic J, Ravotto L, Tsai YC, Figueiredo M, Tyagarajan SK, Weber B, Stoeber M, Gogolla N, Schmidt MH, Adamantidis AR, Fellin T, Burdakov D, Patriarchi T. A genetically encoded sensor for in vivo imaging of orexin neuropeptides. Nat Methods 2022;19:231-41. [PMID: 35145320 DOI: 10.1038/s41592-021-01390-2] [Reference Citation Analysis]
3 Yang J, Gao J. Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy. Expert Review of Clinical Pharmacology 2019;12:723-8. [DOI: 10.1080/17512433.2019.1632705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gan J, Chen Z, Han J, Ma L, Liu S, Wang XD, Ji Y. Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:765701. [PMID: 34867809 DOI: 10.3389/fendo.2021.765701] [Reference Citation Analysis]
5 Giorgi FS, Galgani A, Puglisi-Allegra S, Busceti CL, Fornai F. The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer's disease. J Neural Transm (Vienna) 2021;128:589-613. [PMID: 33942174 DOI: 10.1007/s00702-021-02338-8] [Reference Citation Analysis]
6 Demidova A, Kahl E, Fendt M. Orexin deficiency affects sensorimotor gating and its amphetamine-induced impairment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110517] [Reference Citation Analysis]
7 Gompf HS, Anaclet C. The neuroanatomy and neurochemistry of sleep-wake control. Curr Opin Physiol 2020;15:143-51. [PMID: 32647777 DOI: 10.1016/j.cophys.2019.12.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Ambati A, Luo G, Pradhan E, Louis J, Lin L, Leib RD, Ollila HM, Poiret T, Adams C, Mignot E. Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines. Vaccines (Basel) 2020;8:E630. [PMID: 33142956 DOI: 10.3390/vaccines8040630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dale NC, Hoyer D, Jacobson LH, Pfleger KDG, Johnstone EKM. Orexin Signaling: A Complex, Multifaceted Process. Front Cell Neurosci 2022;16:812359. [DOI: 10.3389/fncel.2022.812359] [Reference Citation Analysis]
10 Fabara SP, Ortiz JF, Anas Sohail A, Hidalgo J, Altamimi A, Tama B, Patel UK. Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review. Cureus 2021;13:e16095. [PMID: 34345566 DOI: 10.7759/cureus.16095] [Reference Citation Analysis]
11 Chunduri A, Crusio WE, Delprato A. Narcolepsy in Parkinson's disease with insulin resistance. F1000Res 2020;9:1361. [DOI: 10.12688/f1000research.27413.3] [Reference Citation Analysis]
12 Baiardi S, Pizza F, Polischi B, Moresco M, Abu-Rumeileh S, Plazzi G, Parchi P. Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1. Sleep 2020;43:zsz215. [PMID: 31552425 DOI: 10.1093/sleep/zsz215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Varshavsky A. On the cause of sleep: Protein fragments, the concept of sentinels, and links to epilepsy. Proc Natl Acad Sci U S A 2019;116:10773-82. [PMID: 31085645 DOI: 10.1073/pnas.1904709116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Murillo-Rodríguez E, Budde H, Veras AB, Rocha NB, Telles-Correia D, Monteiro D, Cid L, Yamamoto T, Machado S, Torterolo P. The Endocannabinoid System May Modulate Sleep Disorders in Aging. Curr Neuropharmacol 2020;18:97-108. [PMID: 31368874 DOI: 10.2174/1570159X17666190801155922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Schneider WT, Vas S, Nicol AU, Morton AJ. Abnormally abrupt transitions from sleep-to-wake in Huntington's disease sheep (Ovis aries) are revealed by automated analysis of sleep/wake transition dynamics. PLoS One 2021;16:e0251767. [PMID: 33984047 DOI: 10.1371/journal.pone.0251767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nirogi R, Benade V, Daripelli S, Subramanian R, Kamuju V, Bhyrapuneni G, Muddana NR, Mekala VR, Petlu S, Jayarajan P, Badange R, Shinde A, Jasti V. Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation. Psychopharmacology (Berl) 2021;238:1495-511. [PMID: 33550481 DOI: 10.1007/s00213-021-05779-x] [Reference Citation Analysis]
17 Kakizaki M, Tsuneoka Y, Takase K, Kim SJ, Choi J, Ikkyu A, Abe M, Sakimura K, Yanagisawa M, Funato H. Differential Roles of Each Orexin Receptor Signaling in Obesity. iScience 2019;20:1-13. [PMID: 31546102 DOI: 10.1016/j.isci.2019.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
18 Blattner MS, Day GS. Sleep Disturbances in Patients with Autoimmune Encephalitis. Curr Neurol Neurosci Rep 2020;20:28. [PMID: 32524504 DOI: 10.1007/s11910-020-01048-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
19 Järvelä M, Raatikainen V, Kotila A, Kananen J, Korhonen V, Uddin LQ, Ansakorpi H, Kiviniemi V. Lag Analysis of Fast fMRI Reveals Delayed Information Flow Between the Default Mode and Other Networks in Narcolepsy. Cereb Cortex Commun 2020;1:tgaa073. [PMID: 34296133 DOI: 10.1093/texcom/tgaa073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Han Y, Yuan K, Zheng Y, Lu L. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders. Neurosci Bull 2020;36:432-48. [PMID: 31782044 DOI: 10.1007/s12264-019-00447-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
21 Torstensen EW, Pickering L, Kornum BR, Wanscher B, Baandrup L, Jennum PJ. Diagnostic value of actigraphy in hypersomnolence disorders. Sleep Med 2021;85:1-7. [PMID: 34265481 DOI: 10.1016/j.sleep.2021.06.033] [Reference Citation Analysis]
22 Cogswell AC, Maski K, Scammell TE, Tucker D, Orban ZS, Koralnik IJ. Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann Clin Transl Neurol 2019;6:2566-72. [PMID: 31730293 DOI: 10.1002/acn3.50908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Treu SP, Plante DT. Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis. Sleep Med 2021;85:230-8. [PMID: 34364094 DOI: 10.1016/j.sleep.2021.07.007] [Reference Citation Analysis]
24 Guevarra JT, Hiensch R, Varga AW, Rapoport DM. Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility. Nat Sci Sleep 2020;12:709-19. [PMID: 33117007 DOI: 10.2147/NSS.S264140] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Costa A, Monti J, Torterolo P. Hypocretin (orexin) immunoreactivity in the feline midbrain: Relevance for the generation of wakefulness. J Chem Neuroanat 2020;105:101769. [PMID: 32145304 DOI: 10.1016/j.jchemneu.2020.101769] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Murillo-Rodríguez E, Millán-Aldaco D, Palomero-Rivero M, Morales-Lara D, Mechoulam R, Drucker-Colín R. Cannabidiol Partially Blocks the Excessive Sleepiness in Hypocretindeficient Rats: Preliminary Data. CNS Neurol Disord Drug Targets 2019;18:705-12. [PMID: 31642794 DOI: 10.2174/1871527318666191021143300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Matzeu A, Martin-Fardon R. Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sci 2020;10:E226. [PMID: 32290110 DOI: 10.3390/brainsci10040226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
28 Elliott JE, Keil AT, Mithani S, Gill JM, O’neil ME, Cohen AS, Lim MM. Dietary Supplementation With Branched Chain Amino Acids to Improve Sleep in Veterans With Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Pilot and Feasibility Trial. Front Syst Neurosci 2022;16:854874. [DOI: 10.3389/fnsys.2022.854874] [Reference Citation Analysis]
29 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2021. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
30 Zhang D, Perrey DA, Decker AM, Langston TL, Mavanji V, Harris DL, Kotz CM, Zhang Y. Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists. J Med Chem 2021;64:8806-25. [PMID: 34101446 DOI: 10.1021/acs.jmedchem.1c00841] [Reference Citation Analysis]
31 O'Hearn LA. The therapeutic properties of ketogenic diets, slow-wave sleep, and circadian synchrony. Curr Opin Endocrinol Diabetes Obes 2021;28:503-8. [PMID: 34269711 DOI: 10.1097/MED.0000000000000660] [Reference Citation Analysis]
32 Alvente S, Berteotti C, Bastianini S, Lo Martire V, Matteoli G, Silvani A, Zoccoli G. Autonomic mechanisms of blood pressure alterations during sleep in orexin/hypocretin-deficient narcoleptic mice. Sleep 2021;44:zsab022. [PMID: 33517440 DOI: 10.1093/sleep/zsab022] [Reference Citation Analysis]
33 Tran S, Prober DA. Validation of Candidate Sleep Disorder Risk Genes Using Zebrafish. Front Mol Neurosci 2022;15:873520. [DOI: 10.3389/fnmol.2022.873520] [Reference Citation Analysis]
34 Funato H. Forward genetic approach for behavioral neuroscience using animal models. Proc Jpn Acad Ser B Phys Biol Sci 2020;96:10-31. [PMID: 31932526 DOI: 10.2183/pjab.96.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Mediavilla C. Bidirectional gut-brain communication: A role for orexin-A. Neurochem Int 2020;141:104882. [PMID: 33068686 DOI: 10.1016/j.neuint.2020.104882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Shetgaonkar GG, Kumar L. Chemistry of Neurochemicals: Psychopharmaceuticals and Neuropeptides. In: Mathew B, Thomas Parambi DG, editors. Principles of Neurochemistry. Singapore: Springer; 2020. pp. 41-70. [DOI: 10.1007/978-981-15-5167-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Dye TJ, Simakajornboon N. Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus. Pediatr Pulmonol 2021. [PMID: 34021733 DOI: 10.1002/ppul.25512] [Reference Citation Analysis]
38 Cordani R, Veneruso M, Napoli F, Di Iorgi N, Milanaccio C, Consales A, Disma N, De Grandis E, Maghnie M, Nobili L. Sleep Disturbances in Pediatric Craniopharyngioma: A Systematic Review. Front Neurol 2022;13:876011. [DOI: 10.3389/fneur.2022.876011] [Reference Citation Analysis]
39 Luo G, Yogeshwar S, Lin L, Mignot EJ. T cell reactivity to regulatory factor X4 in type 1 narcolepsy. Sci Rep 2021;11:7841. [PMID: 33837283 DOI: 10.1038/s41598-021-87481-8] [Reference Citation Analysis]
40 Reading PJ. Update on narcolepsy. J Neurol 2019;266:1809-15. [DOI: 10.1007/s00415-019-09310-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Ahmadi-soleimani SM, Mianbandi V, Azizi H, Azhdari-zarmehri H, Ghaemi-jandabi M, Abbasi-mazar A, Mohajer Y, Darana SP. Coregulation of sleep-pain physiological interplay by orexin system: An unprecedented review. Behavioural Brain Research 2020;391:112650. [DOI: 10.1016/j.bbr.2020.112650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
42 Li SB, Damonte VM, Chen C, Wang GX, Kebschull JM, Yamaguchi H, Bian WJ, Purmann C, Pattni R, Urban AE, Mourrain P, Kauer JA, Scherrer G, de Lecea L. Hyperexcitable arousal circuits drive sleep instability during aging. Science 2022;375:eabh3021. [PMID: 35201886 DOI: 10.1126/science.abh3021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Brink-Kjaer A, Christensen JAE, Cesari M, Mignot E, Sorensen HBD, Jennum P. Cortical arousal frequency is increased in narcolepsy type 1. Sleep 2021;44:zsaa255. [PMID: 33249455 DOI: 10.1093/sleep/zsaa255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Straat ME, Schinkelshoek MS, Fronczek R, Lammers GJ, Rensen PCN, Boon MR. Role of Brown Adipose Tissue in Adiposity Associated With Narcolepsy Type 1. Front Endocrinol (Lausanne) 2020;11:145. [PMID: 32373062 DOI: 10.3389/fendo.2020.00145] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Meskill GJ, Davis CW, Zarycranski D, Doliba M, Schwartz JC, Dayno JM. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials. CNS Drugs 2021. [PMID: 34935103 DOI: 10.1007/s40263-021-00886-x] [Reference Citation Analysis]
46 Hung CJ, Ono D, Kilduff TS, Yamanaka A. Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy. Elife 2020;9:e54275. [PMID: 32314734 DOI: 10.7554/eLife.54275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Sanford LD, Tang X. Polysomnographic nighttime features of narcolepsy: A systematic review and meta-analysis. Sleep Med Rev 2021;58:101488. [PMID: 33934047 DOI: 10.1016/j.smrv.2021.101488] [Reference Citation Analysis]
48 Cavaliere C, Longarzo M, Fogel S, Engström M, Soddu A. Neuroimaging of Narcolepsy and Primary Hypersomnias. Neuroscientist 2020;26:310-27. [PMID: 32111133 DOI: 10.1177/1073858420905829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Jiang Y, Gen N, Wang P, Feng N, Lu X. Prednisolone induces sleep disorders via inhibition of melatonin secretion by the circadian rhythm in zebrafish. Biomed Pharmacother 2022;147:112590. [PMID: 35007999 DOI: 10.1016/j.biopha.2021.112590] [Reference Citation Analysis]
50 Zielinski MR, Systrom DM, Rose NR. Fatigue, Sleep, and Autoimmune and Related Disorders. Front Immunol 2019;10:1827. [PMID: 31447842 DOI: 10.3389/fimmu.2019.01827] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
51 Almeneessier AS, Alballa NS, Alsalman BH, Aleissi S, Olaish AH, BaHammam AS. A 10-Year Longitudinal Observational Study Of Cataplexy In A Cohort Of Narcolepsy Type 1 Patients. Nat Sci Sleep 2019;11:231-9. [PMID: 31695532 DOI: 10.2147/NSS.S229105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
52 Zhou S, Yamashita A, Su J, Zhang Y, Wang W, Hao L, Yamanaka A, Kuwaki T. Activity of putative orexin neurons during cataplexy. Mol Brain 2022;15:21. [PMID: 35246205 DOI: 10.1186/s13041-022-00907-w] [Reference Citation Analysis]
53 Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med 2020;68:97-109. [PMID: 32032921 DOI: 10.1016/j.sleep.2019.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
54 Coffey AA, Joyal AA, Yamanaka A, Scammell TE. The Impacts of Age and Sex in a Mouse Model of Childhood Narcolepsy. Front Neurosci 2021;15:644757. [PMID: 33746708 DOI: 10.3389/fnins.2021.644757] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Stanojlovic M, Pallais JP, Kotz CM. Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease. Int J Mol Sci 2021;22:E795. [PMID: 33466831 DOI: 10.3390/ijms22020795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Gao F, Liu T, Tuo M, Chi S. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target. Neurosci Lett 2021;765:136247. [PMID: 34530113 DOI: 10.1016/j.neulet.2021.136247] [Reference Citation Analysis]
57 Taksokhan A, Fraigne J, Peever J. Neuroscience: Glutamate neurons in the medial septum control wakefulness. Curr Biol 2021;31:R340-2. [PMID: 33848488 DOI: 10.1016/j.cub.2021.03.006] [Reference Citation Analysis]
58 Barateau L, Jaussent I, Roeser J, Ciardiello C, Kilduff TS, Dauvilliers Y. Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence. Sleep 2021;44:zsab012. [PMID: 33476396 DOI: 10.1093/sleep/zsab012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Li S, Yang J. Pitolisant for treating patients with narcolepsy. Expert Review of Clinical Pharmacology 2020;13:79-84. [DOI: 10.1080/17512433.2020.1714435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
60 Lüthi A. Sleep: The Very Long Posited (VLPO) Synaptic Pathways of Arousal. Curr Biol 2019;29:R1310-2. [PMID: 31846678 DOI: 10.1016/j.cub.2019.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Yüceer H, Gezen Ak D, Benbir Şenel G, Dursun E, Yılmaz V, Karadeniz D, Tüzün E, Küçükali Cİ. Classical complement pathway factor alterations in narcolepsy. Acta Neuropsychiatr 2022;:1-8. [PMID: 35034679 DOI: 10.1017/neu.2021.42] [Reference Citation Analysis]
62 Equihua-Benítez AC, Equihua-Benítez JA, Guzmán-Vásquez K, Prospero-García O, Drucker-Colín R. Orexin cell transplant reduces behavioral arrest severity in narcoleptic mice. Brain Res 2020;1745:146951. [PMID: 32531224 DOI: 10.1016/j.brainres.2020.146951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]